ARMP Armata Pharmaceuticals, Inc.

Develops and commercializes novel bacteriophage-based therapeutics

$1.91  -0.04 (-2.05%)
As of 12/08/2022 15:59:46 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/20/2015
Outstanding shares:  36,144,706
Average volume:  15,478
Market cap:   $69,397,836
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%